Impact Factor: 1.4

Artículos originales \ Editorial

The coming convergence of intravascular imaging with computational processing and modeling

Max L. Olender,a,b, and Elazer R. Edelmana,c

aInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States

bDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States

cCardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts, United States

REC Interv Cardiol. 2021;3:161-163

Left atrial appendage occlusion: a decade of evidence

Ignacio Cruz-González,a,b, and David González-Callea,b

aServicio de Cardiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain

bCIBER de Enfermedades Cardiovasculares (CIBERCV), Spain

REC Interv Cardiol. 2021;3:89-90

In search of excellence in transcatheter and surgical aortic valve implantation

Eduardo Pinar Bermúdez

Sección de Hemodinámica, Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain

REC Interv Cardiol. 2021;3:87-88

FFR post-PCI: what we learned from the FFR-SEARCH study

Nico H.J. Pijls,a,b and Lokien X. van Nunena,

aDepartment of Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands

bDepartment of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands

REC Interv Cardiol. 2021;3:83-86

Virtual vs face-to-face meetings. Can both of them coexist?

Armando Pérez de Prado

Servicio de Cardiología Intervencionista, Hospital Universitario de León, León, Spain

REC Interv Cardiol. 2021;3:5-7

Translational research in the new era of percutaneous mitral valve interventions

Juan F. Granada

Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY, United States

REC Interv Cardiol. 2021;3:1-2

Elderly patients with comorbidities and acute coronary syndrome: ¿primum non nocere?

Miquel Vives-Borràsa, and Alessandro Sionisb,c,

aServicio de Cardiología, Hospital Universitari Son Espases, Institut d’Investigació Sanitària Illes Balears (IdISBa), Palma de Mallorca, Islas Baleares, Spain

bServicio de Cardiología, Hospital de la Santa Creu i Sant Pau, IIB-SantPau, Universitat Autónoma de Barcelona, Barcelona, Spain

cCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain

REC Interv Cardiol. 2021;3:3-4

Use of cangrelor in percutaneous coronary interventions: a “new” weapon in the antithrombotic therapeutic armamentarium

José Luis Ferreiroa,b, and Joan Antoni Gómez-Hospitala,b

aServicio de Cardiología, Hospital Universitario de Bellvitge – IDIBELL, L’Hospitalet de Llobregat, Barcelona, España

bCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), España

REC Interv Cardiol. 2020;2:244-246

Routine endomyocardial biopsy in heart transplantation: in search of lost evidence

José Antonio Vázquez de Prada, and Francisco González-Vílchez

Servicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain

REC Interv Cardiol. 2020;2:242-243